相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Protection Provided by a Herpes Simplex Virus 2 (HSV-2) Glycoprotein C and D Subunit Antigen Vaccine against Genital HSV-2 Infection in HSV-1-Seropositive Guinea Pigs
Sita Awasthi et al.
JOURNAL OF VIROLOGY (2014)
Pan-HSV-2 IgG Antibody in Vaccinated Mice and Guinea Pigs Correlates with Protection against Herpes Simplex Virus 2
William P. Halford et al.
PLOS ONE (2013)
Live Attenuated Herpes Simplex Virus 2 Glycoprotein E Deletion Mutant as a Vaccine Candidate Defective in Neuronal Spread
Sita Awasthi et al.
JOURNAL OF VIROLOGY (2012)
Efficacy Results of a Trial of a Herpes Simplex Vaccine
Robert B. Belshe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Bridging Innate and Adaptive Immunity
William E. Paul
CELL (2011)
HSV-2: in pursuit of a vaccine
Christine Johnston et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Development of a Glycoprotein D-Expressing Dominant-Negative and Replication-Defective Herpes Simplex Virus 2 (HSV-2) Recombinant Viral Vaccine against HSV-2 Infection in Mice
Natalie V. Akhrameyeva et al.
JOURNAL OF VIROLOGY (2011)
Efficient mucosal vaccination mediated by the neonatal Fc receptor
Lilin Ye et al.
NATURE BIOTECHNOLOGY (2011)
A Live-Attenuated HSV-2 ICP0- Virus Elicits 10 to 100 Times Greater Protection against Genital Herpes than a Glycoprotein D Subunit Vaccine
William P. Halford et al.
PLOS ONE (2011)
A mucosal vaccination approach for herpes simplex virus type 2
Rebecca S. Tirabassi et al.
VACCINE (2011)
Effects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pig
David I. Bernstein et al.
VACCINE (2011)
Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs
Richard Brans et al.
BMC MICROBIOLOGY (2010)
Detailed Characterization of T Cell Responses to Herpes Simplex Virus-2 in Immune Seronegative Persons
Christine M. Posavad et al.
JOURNAL OF IMMUNOLOGY (2010)
IMMUNOLOGY Painful Failure of Promising Genital Herpes Vaccine
Jon Cohen
SCIENCE (2010)
HSV ICP0 recruits USP7 to modulate TLR-mediated innate response
Sandrine Daubeuf et al.
BLOOD (2009)
Protection from Herpes Simplex Virus (HSV)-2 Infection with Replication-Defective HSV-2 or Glycoprotein D2 Vaccines in HSV-1-Seropositive and HSV-1-Seronegative Guinea Pigs
Yo Hoshino et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
High-Level Expression of Glycoprotein D by a Dominant-Negative HSV-1 Virus Augments its Efficacy as a Vaccine against HSV-1 Infection
Zheming Lu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Prevention of Genital Herpes Simplex Virus Type 1 and 2 Disease in Mice Immunized with a gD-Expressing Dominant-Negative Recombinant HSV-1
Richard Brans et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Herpes simplex: Insights on pathogenesis and possible vaccines
David M. Koelle et al.
ANNUAL REVIEW OF MEDICINE (2008)
CD8+ T-cell attenuation of cutaneous herpes simplex virus infection reduces the average viral copy number of the ensuing latent infection
Linda M. Wakim et al.
IMMUNOLOGY AND CELL BIOLOGY (2008)
Immunization with a Dominant-Negative Recombinant HSV Type 1 Protects against HSV-1 Skin Disease in Guinea Pigs
Richard Brans et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency
Jared E. Knickelbein et al.
SCIENCE (2008)
Cutting edge:: Recombinant Listeria monocytogenes expressing a single immune-dominant peptide confers protective immunity to herpes simplex virus-1 infection
Mark T. Orr et al.
JOURNAL OF IMMUNOLOGY (2007)
Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation
Jia Zhu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States
Fujie Xu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Mucosal administration of CpG oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 protein vaccination against genital herpes
Sara Tengvall et al.
JOURNAL OF VIROLOGY (2006)
Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes
Nancy Hosken et al.
JOURNAL OF VIROLOGY (2006)
Mucosal vaccines: the promise and the challenge
MR Neutra et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Replication-defective viruses as vaccines and vaccine vectors
T Dudek et al.
VIROLOGY (2006)
Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies
EE Freeman et al.
AIDS (2006)
Impact of immunization with glycoprotein D2/AS04 on herpes simplex virus type 2 shedding into the genital tract in guinea pigs that become infected
N Bourne et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs
Y Hoshino et al.
JOURNAL OF VIROLOGY (2005)
National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976-1994
JA Schillinger et al.
SEXUALLY TRANSMITTED DISEASES (2004)
Herpes simplex virus-specific CD8(+) T cells can clear established lytic infections from skin and nerves and can partially limit the early spread of virus after cutaneous inoculation
A van Lint et al.
JOURNAL OF IMMUNOLOGY (2004)
The dominant-negative herpes simplex virus type 1 (HSV-1) recombinant CJ83193 can serve as an effective vaccine against wild-type HSV-1 infection in mice
H Augustinova et al.
JOURNAL OF VIROLOGY (2004)
Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs
N Bourne et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Glycoprotein-D-adjuvant vaccine to prevent genital herpes
LR Stanberry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Glycoprotein B from strain 17 of herpes simplex virus type I contains an invariant chain homologous sequence that binds to MHC class II molecules
E Sievers et al.
IMMUNOLOGY (2002)
Inhibition of herpes simplex virus type 2 (HSV-2) viral replication by the dominant negative mutant polypeptide of HSV-1 origin binding protein
F Yao et al.
ANTIVIRAL RESEARCH (2002)
Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication
KL Mossman et al.
JOURNAL OF VIROLOGY (2002)
Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection
KM Eidson et al.
JOURNAL OF VIROLOGY (2002)
Monophosphoryl lipid A and QS21 increase CD8 T lymphocyte cytotoxicity to herpes simplex virus-2 infected cell proteins 4 and 27 through IFN-γ and IL-12 production
Z Mikloska et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
